Rosuvastatin and Telmisartan/Amlodipine Interaction Study

Phase 1, randomised, open-label trial of rosuvastatin, telmisartan and amlodipine in hyperlipidemia and hypertension (HTN) (4 arms), sponsored by Jeil Pharmaceutical Co., Ltd. Primary endpoints: Area Under the Plasma Concentration-Time Curve at Steady State at 144 hours and Maximum Plasma Concentration at Steady State at 144 hours. Started Feb 2015; status: completed.